Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma
@article{JGO47519, author = {Verena Schlintl and Florian Huemer and Richard Greil and Lukas Weiss}, title = {Ramucirumab plus FOLFIRI or irinotecan as second-line therapy in advanced or metastatic gastric or gastroesophageal junction adenocarcinoma}, journal = {Journal of Gastrointestinal Oncology}, volume = {12}, number = {2}, year = {2020}, keywords = {}, abstract = {}, issn = {2219-679X}, url = {https://jgo.amegroups.org/article/view/47519} }